Articles and resources

Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)

Persson et al., Clinical Chemistry, 2021
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
Prenatal
23 Nov 2020

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies

Huang et al., BMC Pregnancy and Childbirth, 2020. Provided by the Springer Nature SharedIt content-sharing initiative. No modifications were made on this material. https://creativecommons.org/licenses/by/4.0/
Minimizing Patients’ Risk of Adverse Outcomes in NIPT
Prenatal
26 Set 2020

Minimizing Patients’ Risk of Adverse Outcomes in NIPT

Lawrence Prensky, MS, LCGC, CCGC, discusses the challenges within NIPT on one of the biggest stages in prenatal health, the CoGEN 2020 World Conference.
Making NIPT accessible to all women
Prenatal
26 Giu 2020

Making NIPT accessible to all women

This webinar aims to address some of the obstacles that have prevented the widescale adoption of NIPT. Issues such as: cost, focus, precision and ease of use will all be examined by our speakers and then reevaluated using PerkinElmer's new Vanadis® NIPT platform. Speakers include Prof. Howard Cuckle (Tel Aviv University, Israel) and Dr Alka Chaubey (PerkinElmer Global Genomic, USA)
Universal access to NIPT: Cost-effective and precise cell-free DNA testing
Prenatal
08 Giu 2020

Universal access to NIPT: Cost-effective and precise cell-free DNA testing

This PerkinElmer satellite symposium organized at the European Society of Human Genetics (ESHG) Virtual Conference 2020 presents two laboratories’ experience with Vanadis® NIPT, an automated, non-sequencing cell-free DNA testing platform. Speakers include Dr. Alka Chaubey (PerkinElmer Global Genomic, USA) and Prof. Barbara Pasini (University of Turin, Italy).
LifeCycle™ software brochure
Prenatal
24 Apr 2020

LifeCycle™ software brochure

Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma
Prenatal
19 Ago 2019

Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma

Ericsson et al., Prenatal Diagnosis. 2019
Implementation and Validation of a High-Precision, Non-NGS NIPT Platform
Prenatal
26 Set 2018

Implementation and Validation of a High-Precision, Non-NGS NIPT Platform

This Genomeweb webinar provides a comprehensive overview of Vanadis® NIPT system, an automated, high-precision non-invasive prenatal testing platform. Speakers: Dr. Glenn Palomaki (Women & Infants Hospital, Rhode Island, USA) and Dr Jérémie Gautier (Cerba Xpert, France).
Imaging single DNA molecules for high precision NIPT
Prenatal
14 Mar 2018

Imaging single DNA molecules for high precision NIPT

Dahl et al., Scientific Reports, 2018
The new era of cell-free DNA testing
Prenatal
15 Mag 2017

The new era of cell-free DNA testing

Kypros Nicolaides, Professor at King’s College Hospital, London (UK) and founder of Fetal Medicine Foundation (FMF) presents is perspective on the clinical implementation of cell-free DNA testing, in particular which chromosomal abnormalities should be screened for and the importance of the fetal fraction.

È possibile che i prodotti non siano disponibili in alcuni Paesi a seconda della legislazione locale, come negli Stati Uniti e in Canada. Verificare la disponibilità rivolgendosi al rappresentante locale.

PerkinElmer non sostiene e non formula raccomandazioni in merito a ricerche, farmaci o trattamenti. Tutte le informazioni presentate sono esclusivamente a titolo informativo e non intendono offrire alcun parere medico. Per raccomandazioni specifiche a ciascun Paese consultare l’operatore sanitario locale.